Status:
UNKNOWN
COgilus Remediation in Alzheimer Patients (CORA)
Lead Sponsor:
University Hospital, Angers
Conditions:
Patient Satisfaction
Neurocognitive Disorders
Eligibility:
All Genders
18+ years
Brief Summary
This study evaluates the usability of a new tablet PC application to stimulate cognitive functions. Patients hospitalized in a geriatric ward (day or complete hospitalisation) but also their informal ...
Detailed Description
Attention span is one of the most frequently and early impaired cognitive functions during aging, especially in neurocognitive disorders such as Alzheimer's disease. Decline of attention span can lead...
Eligibility Criteria
Inclusion
- no opposition to be part of the study
- patients:
- over 65 years old
- to be hospitalised in geriatric medicine department of Angers University Hospital
- mild cognitive impairment (winblad criterion) or minor neurocognitive disorder du to alzheimer disease or early major neurocognitive disorder du to alzheimer disease (DSM V and NINCDS-ADRDA criterion)
- unformal cargivers and health profesionnals:
- over 18 years old
Exclusion
- depression (geriatric depression scale 15 items: over 10/15)
- delirum (assessed with the confusion assessment methode)
- to be under legal protection
Key Trial Info
Start Date :
October 30 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 30 2020
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04113577
Start Date
October 30 2019
End Date
October 30 2020
Last Update
October 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Angers University Hospital
Angers, France, 49933 cedex 9